Diamant Thaci: Clinical Trials

2 trials sponsored by Diamant Thaci, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Withdrawn 1

Follow Diamant Thaci: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients
Apremilast;Apremilast;Apremilast 10 MG; 20 MG; 30 MG Oral Tablet - Moderate to Severe Plaque Psoriasis
Phase 4WithdrawnDiamant Thaci2017-10-232019-04-18
Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients
Secukinumab - Psoriasis Vulgaris
CompletedDiamant Thaci402016-10-012019-08-16

Interventions

Tablets (1)  ·  secukinumab (1)

Countries

Germany (2)

NIH funding

2016 (1)